MovDisordV3, Main, Exploration, bibRecord, 004E54

Dyskinesias assessment in phase II studies

Identifieur interne : 004E54 ( Main/Exploration ); précédent : 004E53; suivant : 004E55

Dyskinesias assessment in phase II studies

Auteurs : P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France]

Source :

Movement disorders [ 0885-3185 ] ; 1999.

RBID : Pascal:99-0505225

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Dyskinésie, Essai clinique phase II, Exploration, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Biological Transport (physiology), Brain (metabolism), Clinical Protocols, Dopamine (metabolism), Dopamine Agonists (adverse effects), Dopamine Agonists (pharmacokinetics), Dose-Response Relationship, Drug, Dyskinesia, Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (etiology), Exploration, Human, Humans, Levodopa (adverse effects), Levodopa (pharmacokinetics), Parkinson disease, Phase II trial, Sensitivity and Specificity.
MESH :
- chemical , adverse effects : Dopamine Agonists, Levodopa.
- chemical , metabolism : Dopamine.
- diagnosis : Dyskinesia, Drug-Induced.
- etiology : Dyskinesia, Drug-Induced.
- metabolism : Brain.
- chemical , pharmacokinetics : Dopamine Agonists, Levodopa.
- physiology : Biological Transport.
- Clinical Protocols, Dose-Response Relationship, Drug, Humans, Sensitivity and Specificity.

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Dyskinesias assessment in phase II studies</title>
<author><name sortKey="Damier, P" sort="Damier, P" uniqKey="Damier P" first="P." last="Damier">P. Damier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jaillon, C" sort="Jaillon, C" uniqKey="Jaillon C" first="C." last="Jaillon">C. Jaillon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Clavier, I" sort="Clavier, I" uniqKey="Clavier I" first="I." last="Clavier">I. Clavier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I." last="Arnulf">I. Arnulf</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bonnet, A M" sort="Bonnet, A M" uniqKey="Bonnet A" first="A.-M." last="Bonnet">A.-M. Bonnet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bejjani, B P" sort="Bejjani, B P" uniqKey="Bejjani B" first="B.-P." last="Bejjani">B.-P. Bejjani</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0505225</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0505225 INIST</idno>
<idno type="RBID">Pascal:99-0505225</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002D29</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003A95</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002E30</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Damier P:dyskinesias:assessment:in</idno>
<idno type="wicri:Area/Main/Merge">007C79</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10493404</idno>
<idno type="wicri:Area/PubMed/Corpus">004144</idno>
<idno type="wicri:Area/PubMed/Curation">004144</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004224</idno>
<idno type="wicri:Area/Ncbi/Merge">000107</idno>
<idno type="wicri:Area/Ncbi/Curation">000107</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000107</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Damier P:dyskinesias:assessment:in</idno>
<idno type="wicri:Area/Main/Merge">007831</idno>
<idno type="wicri:Area/Main/Curation">004E54</idno>
<idno type="wicri:Area/Main/Exploration">004E54</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Dyskinesias assessment in phase II studies</title>
<author><name sortKey="Damier, P" sort="Damier, P" uniqKey="Damier P" first="P." last="Damier">P. Damier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jaillon, C" sort="Jaillon, C" uniqKey="Jaillon C" first="C." last="Jaillon">C. Jaillon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Clavier, I" sort="Clavier, I" uniqKey="Clavier I" first="I." last="Clavier">I. Clavier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I." last="Arnulf">I. Arnulf</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bonnet, A M" sort="Bonnet, A M" uniqKey="Bonnet A" first="A.-M." last="Bonnet">A.-M. Bonnet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bejjani, B P" sort="Bejjani, B P" uniqKey="Bejjani B" first="B.-P." last="Bejjani">B.-P. Bejjani</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre d'Investigation Clinique-INSERM U 289</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biological Transport (physiology)</term>
<term>Brain (metabolism)</term>
<term>Clinical Protocols</term>
<term>Dopamine (metabolism)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Dopamine Agonists (pharmacokinetics)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Dyskinesia</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Exploration</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (pharmacokinetics)</term>
<term>Parkinson disease</term>
<term>Phase II trial</term>
<term>Sensitivity and Specificity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Dopamine Agonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Biological Transport</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Protocols</term>
<term>Dose-Response Relationship, Drug</term>
<term>Humans</term>
<term>Sensitivity and Specificity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Dyskinésie</term>
<term>Essai clinique phase II</term>
<term>Exploration</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
<orgName><li>Hôpital de la Salpêtrière</li>
</orgName>
</list>
<tree><country name="France"><noRegion><name sortKey="Damier, P" sort="Damier, P" uniqKey="Damier P" first="P." last="Damier">P. Damier</name>
</noRegion>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name>
<name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I." last="Arnulf">I. Arnulf</name>
<name sortKey="Bejjani, B P" sort="Bejjani, B P" uniqKey="Bejjani B" first="B.-P." last="Bejjani">B.-P. Bejjani</name>
<name sortKey="Bonnet, A M" sort="Bonnet, A M" uniqKey="Bonnet A" first="A.-M." last="Bonnet">A.-M. Bonnet</name>
<name sortKey="Clavier, I" sort="Clavier, I" uniqKey="Clavier I" first="I." last="Clavier">I. Clavier</name>
<name sortKey="Jaillon, C" sort="Jaillon, C" uniqKey="Jaillon C" first="C." last="Jaillon">C. Jaillon</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E54 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E54 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:99-0505225
   |texte=   Dyskinesias assessment in phase II studies
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Dyskinesias assessment in phase II studies

Dyskinesias assessment in phase II studies

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.